Rethinking the clinical development pathway to add value to your pipeline whilst maximising efficiency and shortening clinical timelines http://www.clinicaldevelopmentleadersforum.com/ Conference Dates: 15th- 17th October 2012 Venue: Vienna, Austria NextLevel Pharma’s “Clinical Development Leaders Forum” will bring together regulators, experienced investigators and study personnel as well as clinical trial experts from pharma and CROs. We will [...]
In a paper published in the online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington’s disease (HD). The findings explain a fundamental aspect of how [...]
Cleveland Clinic researchers have discovered that a naturally occurring molecule may play a role in preventing plaque buildup inside arteries, possibly leading to new plaque-fighting drugs and improved screening of patients at risk of developing atherosclerosis. Sometimes called hardening or clogging of the arteries, atherosclerosis is the buildup of cholesterol, fatty cells, and inflammatory deposits [...]
Blood flow to the heart often is interrupted during a heart attack or cardiac surgery. But when blood flow resumes, the heart may still falter. That’s because collateral damage can occur as blood re-enters the heart, potentially slowing recovery and causing future cardiac troubles. Researchers investigating this type of secondary heart damage have been stymied [...]
In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize [...]
